CDIX (Cardiff Lexington) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CDIX Cardiff Lexington Corp CDIX
27 GF Score
Price $0.51
GF Value $0.08
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Cardiff Lexington Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CDIX
27GF Score
Cardiff Lexington Corp CDIX
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cardiff Lexington (CDIX) Overvalued in 2026?

Based on GuruFocus' analysis, Cardiff Lexington stock appears to be overvalued. The current stock price of $0.51 is trading 537.5% above its estimated GF Value™ of $0.08. GuruFocus considers Cardiff Lexington to be Significantly Overvalued.

Key valuation signals for CDIX:

  • Interest Received:
  • GF Value™: $0.08 vs. price of $0.51 (537.5% above fair value)
  • GF Score™: 27/100 with 7 warning signs

No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cardiff Lexington Business Description

Address 710 East Main Street, Lexington, KY, USA, 40502
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
27GF Score

Get the complete analysis for CDIX

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.08
GF Value